Upload
muchamad-indung-hikmawan
View
214
Download
0
Embed Size (px)
Citation preview
7/31/2019 Adverse Effect
1/11
Adverse Effect:ethambutol has its pharmacokinetic parameters altered by aluminium hydroxide
Severity Level:Moderate - These medications may interact resulting in the potential deterioration of the patient's condition. The patient should be monitored forthe possible manifestations of the interaction. Medical intervention or a change in therapy may be required.
Documentation Level:Good - Although controlled studies may not have been performed, several case reports have been documented and other data strongly su ggeststhis interaction exists.
ethambutol belongs to the class of EthambutolAntitubercular antibiotic.
aluminium hydroxide belongs to the class of Aluminium hydroxide
Aluminium hydroxide is used as an antacid and phosphate-binder.
Probable Mechanism:Aluminium hydroxide gel reduced and delayed ethambutol serum levels in a study involving 13 tuberculous patients. Aluminium/magnesiumhydroxide coadministration resulted in a reduction in the extent of ethambutol absorption and peak serum levels, in a study involving 14 healthysubjects. The clinical significance of these interactions is undetermined. Administer oral ethambutol and aluminium hydroxide four hours apart tominimise potential interactions.
Actions to be Taken:1. Administer drugs separately.2. Use combination with caution.
ceftriaxone
acenocoumarol
4-Moderate
2-Limited
ceftriaxone causesadditive toxicitywithacenocoumarol
http://www.mims.com/Indonesia/Viewer/Html/DrugAlertSig.htmhttp://www.mims.com/Indonesia/Viewer/Html/DrugAlertSig.htmhttp://www.mims.com/Indonesia/Viewer/Html/LikeLiHood.htmhttp://www.mims.com/Indonesia/Viewer/Html/LikeLiHood.htmhttp://www.mims.com/Indonesia/Viewer/Html/LikeLiHood.htmhttp://www.mims.com/Indonesia/Viewer/Html/DrugAlertSig.htm7/31/2019 Adverse Effect
2/11
ceftriaxone alteplase
4-Moderate
1-NotEstablished
ceftriaxone causesadditive toxicity withalteplase
ceftriaxonerecombinant tissueplasminogenactivator
4-Moderate
1-NotEstablished
ceftriaxone causesadditive toxicity withrecombinant tissueplasminogen activator
ceftriaxonetissue plasminogenactivator
4-Moderate
1-NotEstablished
ceftriaxone causesadditive toxicity withtissue plasminogenactivator
ceftriaxone tissue-typeplasminogenactivator
4-Moderate
1-NotEstablished
ceftriaxone causes
additive toxicity withtissue-typeplasminogen activator
ceftriaxonealuminumacetylsalicylate
3-Minor1-NotEstablished
ceftriaxone causesadditive toxicity withaluminumacetylsalicylate
ceftriaxone aluminiumacetylsalicylate 3-Minor 1-NotEstablished
ceftriaxone causes
additive toxicity withaluminiumacetylsalicylate
ceftriaxone aluminium aspirin 3-Minor1-NotEstablished
ceftriaxone causesadditive toxicity withaluminium aspirin
ceftriaxone aluminum aspirin 3-Minor1-NotEstablished
ceftriaxone causesadditive toxicity with
7/31/2019 Adverse Effect
3/11
aluminum aspirin
ceftriaxone aminosalicylic acid 3-Minor1-NotEstablished
ceftriaxone causesadditive toxicity with
aminosalicylic acid
ceftriaxone4-aminosalicylicacid
3-Minor1-NotEstablished
ceftriaxone causesadditive toxicity with 4-aminosalicylic acid
ceftriaxonecalcium para-aminosalicylate
3-Minor1-NotEstablished
ceftriaxone causesadditive toxicity withcalcium para-aminosalicylate
ceftriaxonepara-aminosalicylicacid
3-Minor1-NotEstablished
ceftriaxone causesadditive toxicity withpara-aminosalicylicacid
ceftriaxone pas 3-Minor1-NotEstablished
ceftriaxone causesadditive toxicity withpas
ceftriaxonesodium
aminosalicylate
3-Minor1-Not
Established
ceftriaxone causesadditive toxicity with
sodium aminosalicylate
ceftriaxonesodium p-aminosalicylate
3-Minor1-NotEstablished
ceftriaxone causesadditive toxicity withsodium p-aminosalicylate
ceftriaxone anistreplase4-Moderat
1-NotEstablished
ceftriaxone causesadditive toxicity with
7/31/2019 Adverse Effect
4/11
e anistreplase
ceftriaxone aspirin 3-Minor1-NotEstablished
ceftriaxone causesadditive toxicity with
aspirin
ceftriaxone acetylsal acid 3-Minor1-NotEstablished
ceftriaxone causesadditive toxicity withacetylsal acid
ceftriaxone acetylsalicylic acid 3-Minor1-NotEstablished
ceftriaxone causesadditive toxicity withacetylsalicylic acid
ceftriaxonesalicylic acid
acetate3-Minor
1-Not
Established
ceftriaxone causesadditive toxicity withsalicylic acid acetate
ceftriaxone benorilate 3-Minor1-NotEstablished
ceftriaxone causesadditive toxicity withbenorilate
ceftriaxone benorylate 3-Minor1-NotEstablished
ceftriaxone causesadditive toxicity withbenorylate
ceftriaxone bismuth salicylate 3-Minor 1-NotEstablished
ceftriaxone causesadditive toxicity withbismuth salicylate
ceftriaxonebismuthoxysalicylate
3-Minor1-NotEstablished
ceftriaxone causesadditive toxicity withbismuth oxysalicylate
ceftriaxonebismuthsubsalicylate
3-Minor1-NotEstablished
ceftriaxone causesadditive toxicity with
7/31/2019 Adverse Effect
5/11
bismuth subsalicylate
ceftriaxonecarbasalatecalcium
3-Minor1-NotEstablished
ceftriaxone causesadditive toxicity with
carbasalate calcium
ceftriaxonecholine magnesiumtrisalicylate
3-Minor1-NotEstablished
ceftriaxone causesadditive toxicity withcholine magnesiumtrisalicylate
ceftriaxone choline salicylate 3-Minor1-NotEstablished
ceftriaxone causesadditive toxicity withcholine salicylate
ceftriaxone ciclosporin4-Moderate
2-Limited
ceftriaxone mayincrease the serumconcentration ofciclosporin
ceftriaxone cyclosporin4-Moderate
2-Limited
ceftriaxone mayincrease the serumconcentration ofcyclosporin
ceftriaxone cyclosporin A4-Moderate
2-Limited
ceftriaxone may
increase the serumconcentration ofcyclosporin A
ceftriaxone cyclosporine4-Moderate
2-Limited
ceftriaxone mayincrease the serumconcentration ofcyclosporine
7/31/2019 Adverse Effect
6/11
ceftriaxone diflunisal 3-Minor
1-NotEstablished
ceftriaxone causesadditive toxicity withdiflunisal
ceftriaxone diflunisal lysine 3-Minor 1-NotEstablished
ceftriaxone causesadditive toxicity withdiflunisal lysine
ceftriaxone etenzamide 3-Minor1-NotEstablished
ceftriaxone causesadditive toxicity withetenzamide
ceftriaxone ethenzamide 3-Minor1-NotEstablished
ceftriaxone causesadditive toxicity withethenzamide
ceftriaxone ethoxybenzamide 3-Minor1-NotEstablished
ceftriaxone causesadditive toxicity withethoxybenzamide
ceftriaxone fluindione4-Moderate
2-Limitedceftriaxone causesadditive toxicity withfluindione
ceftriaxone guacetisal 3-Minor1-NotEstablished
ceftriaxone causesadditive toxicity with
guacetisal
ceftriaxone heparin4-Moderate
1-NotEstablished
ceftriaxone causesadditive toxicity withheparin
ceftriaxone calcium heparin4-Moderate
1-NotEstablished
ceftriaxone causesadditive toxicity withcalcium heparin
7/31/2019 Adverse Effect
7/11
ceftriaxone heparin calcium
4-Moderate
1-NotEstablished
ceftriaxone causesadditive toxicity withheparin calcium
ceftriaxone heparinmagnesium
4-Moderate
1-NotEstablished
ceftriaxone causesadditive toxicity withheparin magnesium
ceftriaxone heparin sodium4-Moderate
1-NotEstablished
ceftriaxone causesadditive toxicity withheparin sodium
ceftriaxoneheparin sodium,porcine
4-Moderat
e
1-NotEstablished
ceftriaxone causesadditive toxicity withheparin sodium,
porcine
ceftriaxone heparin, porcine4-Moderate
1-NotEstablished
ceftriaxone causesadditive toxicity withheparin, porcine
ceftriaxone imidazole salicylate 3-Minor1-NotEstablished
ceftriaxone causesadditive toxicity withimidazole salicylate
ceftriaxone imidazole-2-hydroxybenzoate
3-Minor 1-NotEstablished
ceftriaxone causes
additive toxicity withimidazole-2-hydroxybenzoate
ceftriaxone lysine aspirin 3-Minor1-NotEstablished
ceftriaxone causesadditive toxicity withlysine aspirin
ceftriaxone acetylsalicylate 3-Minor 1-Not ceftriaxone causes
7/31/2019 Adverse Effect
8/11
lysine Established additive toxicity withacetylsalicylate lysine
ceftriaxone
lysine
acetylsalicylate 3-Minor
1-Not
Established
ceftriaxone causes
additive toxicity withlysine acetylsalicylate
ceftriaxonemagnesiumsalicylate
3-Minor1-NotEstablished
ceftriaxone causesadditive toxicity withmagnesium salicylate
ceftriaxonemorpholinesalicylate
3-Minor1-NotEstablished
ceftriaxone causesadditive toxicity withmorpholine salicylate
ceftriaxone phenindione4-Moderate
2-Limitedceftriaxone causesadditive toxicity withphenindione
ceftriaxone reteplase4-Moderate
1-NotEstablished
ceftriaxone causesadditive toxicity withreteplase
ceftriaxone salicylamide 3-Minor1-NotEstablished
ceftriaxone causesadditive toxicity withsalicylamide
ceftriaxone salol 3-Minor1-NotEstablished
ceftriaxone causesadditive toxicity withsalol
ceftriaxone phenyl salicylate 3-Minor1-NotEstablished
ceftriaxone causesadditive toxicity withphenyl salicylate
ceftriaxone salsalate 3-Minor 1-Not ceftriaxone causes
7/31/2019 Adverse Effect
9/11
Established additive toxicity withsalsalate
ceftriaxone salicyl salicylate 3-Minor
1-Not
Established
ceftriaxone causes
additive toxicity withsalicyl salicylate
ceftriaxonesalicylosalicylicacid
3-Minor1-NotEstablished
ceftriaxone causesadditive toxicity withsalicylosalicylic acid
ceftriaxone salysal 3-Minor1-NotEstablished
ceftriaxone causesadditive toxicity withsalysal
ceftriaxone sasapyrine 3-Minor 1-NotEstablished
ceftriaxone causesadditive toxicity withsasapyrine
ceftriaxone sodium salicylate 3-Minor1-NotEstablished
ceftriaxone causesadditive toxicity withsodium salicylate
ceftriaxonesodium 2-hydroxybenzoate
3-Minor1-NotEstablished
ceftriaxone causesadditive toxicity withsodium 2-
hydroxybenzoate
ceftriaxone streptokinase4-Moderate
1-NotEstablished
ceftriaxone causesadditive toxicity withstreptokinase
ceftriaxone tenecteplase4-Moderate
1-NotEstablished
ceftriaxone causesadditive toxicity withtenecteplase
7/31/2019 Adverse Effect
10/11
ceftriaxone urokinase
4-Moderate
1-NotEstablished
ceftriaxone causesadditive toxicity withurokinase
ceftriaxone vaccine, typhoid 4-Moderate
1-NotEstablished
ceftriaxone reduceseffect of vaccine,typhoid
ceftriaxoneattenuatedsalmonella typhistrain Ty21a
4-Moderate
1-NotEstablished
ceftriaxone reduceseffect of attenuatedsalmonella typhi strainTy21a
ceftriaxone
purified Vi capsular
polysaccharide ofsalmonella typhi
4-
Moderate
1-NotEstablished
ceftriaxone reduceseffect of purified Vi
capsularpolysaccharide ofsalmonella typhi
ceftriaxonesalmonella typhi1000 million
4-Moderate
1-NotEstablished
ceftriaxone reduceseffect of salmonellatyphi 1000 million
ceftriaxoneSalmonella typhiTy-21a, live
attenuated
4-Moderat
e
1-Not
Established
ceftriaxone reduceseffect of Salmonella
typhi Ty-21a, liveattenuated
ceftriaxoneSalmonella typhivaccine
4-Moderate
1-NotEstablished
ceftriaxone reduceseffect of Salmonellatyphi vaccine
ceftriaxoneVi capsularpolysaccharide ofSalmonella typhi
4-Moderate
1-NotEstablished
ceftriaxone reduceseffect of Vi capsularpolysaccharide of
7/31/2019 Adverse Effect
11/11
Salmonella typhi
ceftriaxoneVi polysaccharide
typhoid vaccine
4-Moderat
e
1-Not
Established
ceftriaxone reduceseffect of Vi
polysaccharide typhoidvaccine
ceftriaxone warfarin4-Moderate
2-Limitedceftriaxone causesadditive toxicity withwarfarin
ceftriaxone warfarin potassium4-Moderate
2-Limitedceftriaxone causesadditive toxicity withwarfarin potassium
ceftriaxone warfarin sodium4-Moderate
2-Limitedceftriaxone causesadditive toxicity withwarfarin sodium